Canadian Active & Maintenance Modified Pentasa Study

Clinical trial NCT00603733 · COMPLETED

Trial details

NCT number: NCT00603733
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active Ulcerative Colitis Remission of Ulcerative Colitis

Start date: 2007-10-01
Primary completion: 2011-05-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.